Cyclophosphamide-d8
CAT:
804-HY-17420S1
Size:
1 mg
For Laboratory Research Only. Not for Clinical or Personal Use.
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Cyclophosphamide-d8
UNSPSC Description:
Cyclophosphamide-d8 is deuterium labeled Cyclophosphamide. Cyclophosphamide is a synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic activity, a immunosuppressant.Target Antigen:
DNA Alkylator/Crosslinker; Isotope-Labeled CompoundsType:
Isotope-Labeled CompoundsRelated Pathways:
Cell Cycle/DNA Damage;OthersApplications:
Cancer-programmed cell deathField of Research:
CancerSolubility:
10 mM in DMSOSmiles:
ClC([2H])([2H])C([2H])([2H])N(P1(NCCCO1)=O)C([2H])([2H])C([2H])([2H])ClMolecular Weight:
269.14References & Citations:
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]al-Jafari AA, et al. Inhibition of human acetylcholinesterase by cyclophosphamide. Toxicology. 1995 Jan 19;96(1):1-6.|[3]Harris RN, et al. Carbon tetrachloride-induced increase in the antitumor activity of cyclophosphamide in mice: a pharmacokineticstudy. Cancer Chemother Pharmacol. 1984;12(3):167-72.|[4]Liu P, et al. Administration of cyclophosphamide changes the immune profile of tumor-bearing mice. J Immunother. 2010 Jan;33(1):53-9.|[5]Schwartz PS, et al. Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells. Mol Pharmacol. 2001 Dec;60(6):1268-1279.Shipping Conditions:
Room temperatureClinical Information:
No Development ReportedCAS Number:
1178903-96-2
